DRAK2 regulates myosin light chain phosphorylation in T cells
Journal of Cell Science · 2024
DOI: 10.1242/jcs.261813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2024. Verfasst von Benjamin A Wilander und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Myosin Light Chains, T-Lymphocytes, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, American Lebanese Syrian Associated Charities, NCI NIH HHS.
Abstract (Originalsprache)
Death-associated protein kinase-related apoptosis-inducing kinase-2 (DRAK2; also known as STK17B) is a serine/threonine kinase expressed in T cells. Drak2-deficient (Drak2−/−) mice respond effectively to tumors and pathogens while displaying resistance to T cell-mediated autoimmune disease. However, the molecular mechanisms by which DRAK2 impacts T cell function remain unclear. Gaining further insight into the function of DRAK2 in T cells will shed light on differentially regulated pathways in autoreactive and pathogen-specific T cells, which is crucial for improving autoimmune therapies. Here, we demonstrate that DRAK2 contributes to activation of myosin light chain (MLC2, encoded by Myl2) in both murine and human T cells. In the absence of Drak2, the amount of polymerized actin was decreased, suggesting that DRAK2 modulates actomyosin dynamics. We further show that myosin-dependent T cell functions, such as migration, T cell receptor microcluster accumulation, and conjugation to antigen presenting cells are decreased in the absence of Drak2. These findings reveal that DRAK2 plays an important role in regulating MLC activation within T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- The Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
ORCID-Profile: Stacey K Ogden, Maureen A McGargill
Förderung
- NIAID NIH HHS
- American Lebanese Syrian Associated Charities
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Wilander, B. A., Harris, T. L., Mandarano, A. H., Guy, C. S., Prater, M. S., Pruett-Miller, S. M., Ogden, S. K., & McGargill, M. A. (2024). DRAK2 regulates myosin light chain phosphorylation in T cells. Journal of Cell Science. https://doi.org/10.1242/jcs.261813
Vancouver
Wilander BA, Harris TL, Mandarano AH, Guy CS, Prater MS, Pruett-Miller SM, et al. DRAK2 regulates myosin light chain phosphorylation in T cells. Journal of Cell Science. 2024. doi:10.1242/jcs.261813
BibTeX
@article{Wilander2024,
author = {Wilander, Benjamin A and Harris, Tarsha L and Mandarano, Alexandra H and Guy, Cliff S and Prater, Mollie S and Pruett-Miller, Shondra M and Ogden, Stacey K and McGargill, Maureen A},
title = {DRAK2 regulates myosin light chain phosphorylation in T cells},
journal = {Journal of Cell Science},
year = {2024},
doi = {10.1242/jcs.261813}
}
EUVIMED